Estrogen replacement therapy: indications, contraindications, and agent selection

作者: Morris Notelovitz

DOI: 10.1016/S0002-9378(89)80003-1

关键词:

摘要: Three groups of indications exist for postmenopausal estrogen use: relief symptoms related to deficiency, osteoporosis prophylaxis and treatment, cardioprotection. Estrogen replacement therapy enhances a woman's sense well-being reduces the morbidity, mortality, health care costs associated with atherosclerotic heart disease. There are few absolute contraindications therapy. Many preparations currently available in United States. Establishing equivalencies among different is complicated by many physiologic pharmacologic effects estrogens variety treatment end points used. Most have same biologic effect provided equivalent blood levels achieved. has proved beneficial selected women.

参考文章(104)
Isaac Schiff, Hilla Komarov Sela, Daniel Cramer, Dan Tulchinsky, Kenneth J. Ryan, Endometrial hyperplasia in women on cyclic or continuous estrogen regimens. Fertility and Sterility. ,vol. 37, pp. 79- 82 ,(1982) , 10.1016/S0015-0282(16)45981-9
Clare D. Edman, Estrogen Replacement Therapy Obstetrics & Gynecology. ,vol. 58, pp. 267- 275 ,(1983) , 10.1007/978-1-4612-5525-3_6
Thomas W. McDonald, John F. Annegers, William M. O'Fallon, Malcolm B. Dockerty, George D. Malkasian, Leonard T. Kurland, Exogenous estrogen and endometrial carcinoma: Case-control and incidence study American Journal of Obstetrics and Gynecology. ,vol. 127, pp. 572- 580 ,(1977) , 10.1016/0002-9378(77)90351-9
F. Elkik, A. Gompel, C. Mercier-Bodard, F. Kuttenn, P.N. Guyenne, P. Corvol, P. Mauvais-Jarvis, Effects of percutaneous estradiol and conjugated estrogens on the level of plasma proteins and triglycerides in postmenopausal women. American Journal of Obstetrics and Gynecology. ,vol. 143, pp. 888- 892 ,(1982) , 10.1016/0002-9378(82)90468-9
C.Ann Mashchak, Rogerio A. Lobo, Ryoko Dozono-Takano, Peter Eggena, Robert M. Nakamura, Paul F. Brenner, Daniel R. Mishell, Comparison of pharmacodynamic properties of various estrogen formulations. American Journal of Obstetrics and Gynecology. ,vol. 144, pp. 511- 518 ,(1982) , 10.1016/0002-9378(82)90218-6
Edward E. Wallach, R. Don Gambrell, The menopause: benefits and risks of estrogen-progestogen replacement therapy Fertility and Sterility. ,vol. 37, pp. 457- 474 ,(1982) , 10.1016/S0015-0282(16)46149-2
Clifford R. Kay, Progestogens and arterial disease—Evidence from the Royal College of General Practitioners' study American Journal of Obstetrics and Gynecology. ,vol. 142, pp. 762- 765 ,(1982) , 10.1016/S0002-9378(16)32485-1
Kristi J. Ferguson, Estrogen Replacement Therapy Archives of Internal Medicine. ,vol. 149, pp. 133- 136 ,(1989) , 10.1001/ARCHINTE.1989.00390010123016
BRUCE ETTINGER, Long-Term Estrogen Replacement Therapy Prevents Bone Loss and Fractures Annals of Internal Medicine. ,vol. 102, pp. 319- 324 ,(1985) , 10.7326/0003-4819-102-3-319